Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer - a podcast by ReachMD

CME credits: 0.25

Valid until: 28-09-2021

Claim your CME credit at https://reachmd.com/programs/cme/changing-landscape-braf-v600e-mutated-metastatic-colorectal-cancer-treatment/11862/

Dr. Scott Kopetz, Prof. Eric Van Cutsem, and Dr. Josep Tabernero engage in a panel discussion with a focus on the practice-changing initial and subsequently updated mature findings from the BEACON trial. These pivotal findings alter the standard of care for patients with BRAF V600E-mutated metastatic colorectal cancer following first-line failure. Find out what you need to know about the latest studies so you can provide the best care for your patients with this condition.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD